New SEC Form D filing
Evia Bio, Inc., 2026-09-28
A new SEC Form D private-offering notice from Minneapolis, MN, a $5,453,532 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Developer of DMSO free cryopreservation media and solutions for cell and gene therapy manufacturers
Filed 4 days agoFiled to raise $5,453,532First money in 2026-09-14Raised so far $5,453,532HQ (as filed) Minneapolis, MNSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified eviabio.com↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Remedy Sports Inc., 2026-09-29, $2.5M, Plymouth, MN
- Q-Immune, Inc., 2026-09-28, $1M, Seattle, WA
- Camelback Intelligence Co., 2026-09-25, $6M, Prior Lake, MN
- Pictura Bio US, Inc., 2026-09-28, $17.5M, Oxford
- VoiceIt Technologies, Inc dba EnQuanta, 2026-09-24, $5M, Eden Prairie, MN
- Vertical Longevity Pharmaceuticals, Inc., 2026-09-28, $110K, Irvine, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.